Diagnosis, removal, or mechanical damaging of tumor using plasmonic nanobubbles
AssigneeMasimo Corporation
InventorsDmitri O. Lapotko, Katsiaryna Hleb
Life of this patent
Estimating the term…
Loading patent…
AssigneeMasimo Corporation
InventorsDmitri O. Lapotko, Katsiaryna Hleb
Estimating the term…
Processes of intraoperative diagnosis and elimination of tumors or micro-tumors or cancer cells or tumor micro-environment (TME) with plasmonic nanobubbles (PNBs) are disclosed. The diagnosis and surgical processes disclosed can improve standard onco-surgery through one or more of the following: real-time intraoperative local detection of MRD in vivo with high cancer sensitivity and specificity; real-time guidance of surgery to precisely eliminate resectable MRD with minimal morbidity by resecting only PNB-positive volume instead of a larger volume; intraoperative selective elimination of unresectable MRD through the mechanical impact of lethal cancer cell-specific PNBs without damaging adjacent normal cells and tissues; and prediction of the surgical outcome through the metrics of PNB signals.
A cancer detection system configured to noninvasively determine a presence of unwanted cancerous material in tissue using plasmonic nanobubbles (“PNBs”), said cancer detection system returning post-electronic processing results to an operator at least at each measurement site during a cancer detection procedure, said cancer detection system comprising:
A noninvasive process to determine cancer in tissue using plasmonic nanobubbles (“PNBs”), said process comprising:
Dependencies are inferred from the claim text.